What is Nurix's mission?

Nurix's mission is to write medicine's next chapter using targeted protein degradation as a new script to outmatch disease.

What is Nurix's technology platform?

Nurix's technology platform combines degraders and DACs (degrader-antibody conjugates) to transform cancer and autoimmune disease treatment through targeted protein degradation.

What are Nurix's degraders?

Nurix's degraders are designed to eliminate disease-causing proteins by harnessing the cell's natural protein degradation machinery.

What are Nurix's DACs?

Nurix's DACs combine the cell specificity of antibodies with the potency, selectivity, and catalytic activity of degraders, delivering innovative medicines with the potential for enhanced precision and improved safety.

What is Nurix's DEL-AI advantage?

Nurix's innovative and prolific DEL-AI drug discovery engine is a key advantage in their development of targeted protein degradation therapies.

Voyager DB

Deep data on millions of local businesses, with verified decision-makers to reveal.

Contact Research

Hand-built prospect lists from human researchers, delivered in 24 hours.

People Search

Find owners and decision-makers by job title, seniority and department.

Chrome Extension

Coldlytics in your browser - prospect any business as you browse the web.

Integrations

Instantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

Voyager DBDeep data on millions of local businesses, with verified decision-makers to reveal.Contact ResearchHand-built prospect lists from human researchers, delivered in 24 hours.People SearchFind owners and decision-makers by job title, seniority and department.Chrome ExtensionColdlytics in your browser - prospect any business as you browse the web.IntegrationsInstantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

PricingPricing AgenciesAgencies BlogBlog

LoginLogin

Nurix Therapeutics

$22.0M revenue • 120 employees • 1700 Owens St Ste 205, San Francisco, CA, 94158, United States

Last Updated May 8, 2025

Own this business? Claim & update this listing →

Company Overview

Company Name

Nurix Therapeutics

Address

1700 Owens St Ste 205, San Francisco, CA, 94158, United States

Website

nurixtx.com

Phone

(415) 660-5320

Approx. Annual Revenue

$22.0M

Employees

120

Established

2018

Locations

About Nurix Therapeutics

Nurix is a biopharmaceutical company based in the United States with approximately 201 employees. The company is focused on developing targeted protein degradation therapies to transform the treatment of cancer and autoimmune diseases using its proprietary DEL-AI drug discovery platform.

Business Profile

Read from the Nurix Therapeutics website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed): 8/10 · Current news and pipeline updates; Clear navigation and contact options

Recent changes

What changed on the Nurix Therapeutics website and Google listing, as detected by Coldlytics on each visit.

Oct 14, 2026
Estimated revenue band moved from $25M-100M to $10M-25M

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →